- Cell Biology
- Product Type
- Research Area
- New Products
- About Tocris
- Contact Us
|Cat. No.||Product Name / Activity|
|Caged Raseglurant (Cat. No. 4416)|
|Stable photoreleaser of L-glutamate|
|Caged D-aspartate; ; NMDA agonist|
|Caged D-AP5 (Cat.No. 0106)|
|Caged glutamate; excited by visible wavelengths|
Tocris offers the following scientific literature for Caged Glutamate Compounds to showcase our products. We invite you to request* or download your copy today!
*Please note that Tocris will only send literature to established scientific business / institute addresses.
Major depressive disorder is characterized by depressed mood and a loss of interest and/or pleasure. Updated in 2015 this poster highlights presynaptic and postsynaptic targets for the potential treatment of major depressive disorder, as well as outlining the pharmacology of currently approved antidepressant drugs.
Parkinson's disease (PD) causes chronic disability and is the second most common neurodegenerative condition. This poster outlines the neurobiology of the disease, as well as highlighting current therapeutic treatments for symptomatic PD, and emerging therapeutic strategies to delay PD onset and progression.